M&A deals, company strategies, pipeline updates and more
Follow our coverage of the 2019 J.P. Morgan Healthcare Conference in San Francisco
The shutdown means 569 employees and 96 contractors will be cut over the next two years.
In 2017, Reckitt Benckiser CEO Rakesh Kapoor touched off some big changes for the company. But he won’t stick around to see them through.
Pfizer has formed a partnership to manufacture some of its drugs in the rapidly growing Asian market.
When doctors first diagnose Parkinson’s patients, their main focus is motor control. And that gives Acadia, maker of Nuplazid, a big job to do.
With the government shutdown now in its fourth week, FDA Commissioner Scott Gottlieb says about 260 medical product inspectors have been recalled.
Can tribal immunity shield a drug—in this case, Restasis—from a patent challenge? Allergan and the Mohawk tribe want the Supreme Court to weigh in.
The Sackler family directed Purdue sales tactics for OxyContin and should be held responsible, Massachusetts' AG says.
Merck's latest additions to the multichannel "It's Tru" campaign for cancer drug Keytruda include two TV ads featuring a real oncologist.
Patients using copay coupons were more likely to stay on their drugs longer, but the vouchers didn't help with outcomes, a new study found.
Exelixis nabbed an FDA nod for Cabometyx in second-line liver cancer, where Stivarga, Opdivo and Keytruda are already battling it out.
